Elad Kaufman

Company: Enveda Biosciences

Job title: Vice President, Program Strategy

Seminars:

Leading the Next Frontier in Treatment of Atopic Dermatitis 3:30 pm

Insights into translating a novel mechanism of action from initial phenotypic identification through target deconvolution Data package for our novel, differentiated and oral agent in AD models in vivo benchmarked against leading standard-of-care therapies / MoAs Share preliminary data on anti-inflammatory mechanism of our agent and potential in indications beyond ADRead more

day: Conference Day Two